DUBLIN, August 30, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "DNA Probes-Based Diagnostics - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The report profiles 46 companies including many key and niche players such as

• Abbott Molecular (USA)
• Affymetrix, Inc. (USA)
• Beckman Coulter, Inc. (USA)
• Becton, Dickinson and Company (USA)
• bioMérieux (France)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• GE Healthcare Life Sciences (UK)
• Luminex Corporation (USA)
• QIAGEN N.V. (Netherlands)
• Siemens Healthineers (Germany)

Key Topics Covered:

1. MARKET DYNAMICS What are DNA-Probes?

DNA-based Diagnostics A Prelude DNA Tests:

Finding Use in Numerous Applications DNA Probes:

Robust Growth Ahead Developed Markets:

Traditional Revenue Contributors The United States:

Unraveling the Country's Edge in DNA-based Diagnostics Infectious Diseases Tests Dominate the DNA-based Diagnostics Market

Developing Countries Excel in Growth Prospects Decoding the Genetic Puzzle Advantages of DNA-Probe

Tests Growth Drivers in a Nutshell Growth Inhibitors in a Nutshell Genetic Profiling of Pathogens:

A Road Less Traveled Roche's Entry into the Hall of Molecular Fame DNA Technology:

An Evolutionary Scan Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005 Market Opportunities

2. MARKET DRIVERS AND TRENDS

World's Aging Population Drives the Popularity of DNA-Probe Tests

Global Aging Population Statistics

Opportunity Indicators

Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics

AIDS: A Global Epidemic

Facts & Figures

Reimbursements: Under the Umbrella

Evolution of New & Virulent Infectious Agents

Challenges in Widespread Deployment of DNA-based Diagnostics

Improvements in Assay Capabilities

Information Handling & Processing: The Soft Side of Diagnostics

Integration: The Ultimate Challenge

DNA Probe Technology Gains Prominence in Diagnosing Vaginitis

Gene Banks

A Ray of Hope for the Future

3. DNA PROBES-BASED DIAGNOSTICS

- A PRIMER Diagnostic Gene Detection Products Molecular Diagnostics:

A Powerful Disease Detection Tool DNA Probes-Based Products Direct Detection of Target Sequence

Nucleic Acid Amplification Gene Detection Using DNA Chips Gene Detection by DNA Sequencing

The Dynamics of Key Enabling Technologies Polymerase Chain Reaction (PCR) In situ Hybridization Chemiluminescence

Gen-Probe Tigris DNA Chips Molecular Diagnostics

A Primer Implications for Clinical Diagnostics Need of the Hour Impact of the Human Genome Project Tailored Patient Management:

An Epitomized Future of Molecular Diagnostics Outlook

4. PRODUCT OVERVIEW

Background

Gene Probe Technology

What is DNA?

DNA Probes

Miniaturization: A Revolutionary Method in DNA Analysis

Gene Chip Technology

DNA Chips

Chromosome Painting Probes

Diagnostic Applications Based on DNA Probes: An Overview

Infectious Diseases

Respiratory Tract Infections

Diagnosis of Mycoplasma

DNA Probes to Detect Legionella Pneumophila

Detecting Tuberculosis through Rapid Diagnostic Tests

How the Technique Works

Limitations

Sexually Transmitted Diseases (STDs)

HIV

HTLV-1 Testing

Hepatitis Testing

Chlamydia DNA Probes

Detection of Intestinal Parasites

Entamoeba Histolytica

Salmonella

Malaria Testing

Identity/Forensics

DNA Profiling: A Key Forensic Tool

DNA-Based Forensic Diagnostics

Tracing Human Origins

Genetic Predisposition

Molecular HLA Testing

Human Leukocyte Antigen (HLA) Typing

Cancer Testing

Cancer: A Deadly Disease Afflicting Millions

Slow Detoxifiers: Potential Cancer Candidates

Improving Cancer Surgery through Diagnostic Tests

Types of Cancer

Chronic Lymphocytic Leukemia (CLL)

Breast Cancer

PCR Screening Technology for Breast Cancer

Eye Cancers

DNA Probes to Detect Retinoblastoma

Others

The Ames test

Genetic Testing

Other Diagnostic Applications

Cystic Fibrosis

Duchenne's Muscular Dystrophy

Huntington's Disease

Diabetes

Detection of Multidrug Resistance

Bacterial Resistance to Antibiotics

5. PRODUCT INTRODUCTIONS/INNOVATIONS DLCS

Unveils In-House DNA Fish Test for Melanoma Agilent Technologies Introduces

New SureFISH Break-Apart Probes Beckman Coulter Life Sciences Rolls Out PerFix-Expose1 and PerFix-nc1

6. RECENT INDUSTRY ACTIVITY

Thermo Fisher Scientific Acquires Affymetrix

Illumina Partners with Memorial Sloan Kettering

Cancer Genetics to Acquire BioServe Biotechnologies

Co-Diagnostics to Acquire DNA Logix' Technologies

Leica Biosystems Takes Over Kreatech Diagnostics and Aotec

7. FOCUS ON SELECT GLOBAL PLAYERS

Abbott Molecular (USA) Affymetrix, Inc. (USA)

Beckman Coulter, Inc. (USA)

Becton, Dickinson and Company (USA)

bioMérieux (France)

F. Hoffmann-La Roche Ltd. (Switzerland)

GE Healthcare Life Sciences (UK)

Luminex Corporation (USA)

QIAGEN N.V. (Netherlands)

Siemens Healthineers (Germany)

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 46 (including Divisions/Subsidiaries 57)

• The United States (37)
• Canada (2)
• Japan (1)
• Europe (13)
• - France (1)
• - Germany (3)
• - The United Kingdom (2)
• - Italy (1)
• - Spain (1)
• - Rest of Europe (5)
• Asia-Pacific (Excluding Japan) (4)

For more information about this report visit http://www.researchandmarkets.com/research/rmrkcf/dna_probesbased

Related Topics: Diagnostics

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-dna-probes-based-diagnostics-strategic-business-report-2015-2022---research-and-markets-300319907.html

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com